
The regulatory framework for pharmaceuticals in Indonesia plays a crucial role in ensuring the safety, efficacy, and quality of medicines available to the public. As a diverse archipelago with a growing population, Indonesia faces unique challenges in regulating its pharmaceutical industry. This article explores the current regulatory landscape for pharmaceuticals in Indonesia, the challenges faced, and the advancements being made to improve the regulatory environment. Visit pafikotairmadidi.org.
Overview of the Regulatory Framework
- National Agency of Drug and Food Control (BPOM)
The National Agency of Drug and Food Control (BPOM) is the primary regulatory authority responsible for overseeing the pharmaceutical …
